Related Experiment Video
Updated: May 5, 2026
Oxygen-Glucose Deprivation and Reoxygenation as an In Vitro Ischemia-Reperfusion Injury Model for Studying Blood-Brain Barrier Dysfunction
Published on: May 7, 2015
Modeling Hypoxia/Reoxygenation Injury in Proximal Tubular Epithelial Cells
Mariano Marin-Blazquez1, Alessandra Tammaro2, Ruben Rabadan-Ros3
1Group of Metabolism and Gene Regulation, UCAM HiTech Sport & Health Innovation Hub, Universidad Católica de Murcia.
Abstract:
Kidney transplantation accounts for approximately 60%-65% of all transplanted solid organs. Most donor kidneys are obtained from deceased individuals, requiring extended cold preservation, which is a known contributor to poor transplant outcomes. Despite current preservation strategies, ischemia-reperfusion injury (IRI) remains an unavoidable consequence of transient blood flow interruption, leading to oxygen and nutrient deprivation. Within the nephron, proximal tubular epithelial cells (PTECs) of the S3 segment are particularly susceptible to IRI due to their high metabolic demand and dependence on mitochondrial oxidative phosphorylation. At the molecular level, IRI disrupts mitochondrial metabolism and reduces ATP production, compromising the energy requirements of proximal tubular epithelial cells (PTECs) and promoting apoptosis and necrosis. To investigate these mechanisms and evaluate potential therapeutic strategies, robust and reproducible in vitro models of renal IRI that accurately recapitulate the metabolic vulnerability of PTECs are essential. Here, we describe a protocol for the induction and assessment of hypoxia/reoxygenation (H/R) injury in murine immortalized PTECs (IM-PTECs). The protocol includes detailed information on the medium composition and culture conditions required to maintain these cells, followed by the induction of H/R injury through controlled hypoxia and reoxygenation phases that closely mimic the ischemia and reperfusion events in transplanted kidneys. This model provides a valuable platform for evaluating the effects of different interventions on renal epithelial cells exposed to H/R injury. The impact of these treatments can be assessed through the analysis of the expression of markers associated with PT damage, as well as through the assessment of the mitochondrial respiratory function. Together, these readouts offer mechanistic insights into compound efficacy and cellular recovery processes, supporting the development of targeted therapies for renal IRI.
Insights
Developing an in vitro model of kidney ischemia-reperfusion injury (IRI) in proximal tubular epithelial cells (PTECs) is crucial. This model aids in evaluating therapies targeting PTEC metabolic vulnerability and improving kidney transplant outcomes.
Area of Science:
- Nephrology
- Transplantation Biology
- Cellular Metabolism
Background:
- Kidney transplantation is common, but donor kidney preservation leads to ischemia-reperfusion injury (IRI).
- Proximal tubular epithelial cells (PTECs), especially in the S3 segment, are highly vulnerable to IRI due to metabolic demands.
- IRI disrupts mitochondrial function, reducing ATP and causing PTEC apoptosis, impacting transplant success.
Purpose of the Study:
- To establish a robust in vitro model for studying renal IRI.
- To investigate the molecular mechanisms of PTEC injury during IRI.
- To provide a platform for evaluating potential therapeutic interventions against renal IRI.
Main Methods:
- Developed a hypoxia/reoxygenation (H/R) protocol for murine immortalized PTECs (IM-PTECs).
- Detailed medium composition and culture conditions for IM-PTEC maintenance and H/R induction.
- Assessed H/R injury by analyzing PTEC damage markers and mitochondrial respiratory function.
Main Results:
- Successfully induced H/R injury in IM-PTECs, mimicking renal IRI conditions.
- The model allows for the assessment of therapeutic interventions.
- Readouts provide mechanistic insights into compound efficacy and cellular recovery.
Conclusions:
- The established H/R model in IM-PTECs accurately recapitulates PTEC metabolic vulnerability to IRI.
- This model is valuable for screening and developing targeted therapies for renal IRI.
- Facilitates research into improving kidney transplant longevity and outcomes.
